• NORTH CAROLINA SOCIETY OF GASTROENTEROLOGY
  • 704.376.3688
  • sbuchanan@meckmed.org
NCSGlogo-300NCSGlogo-only-150NCSGlogo-300NCSGlogo-300
  • Home
  • Events and Education
  • Research
  • About NCSG
    • Board of Directors
    • Board Meetings
    • Grants
    • Partners
    • NCSG Bylaws
JOIN or RENEW HERE
✕
Categories
  • Ulcerative Colitis
Tags
  • Ulcerative Colitis
Study title A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis (QUASAR)
Disease or condition Ulcerative colitis
Study type Interventional  (Clinical Trial)
Intervention/treatment Guselkumab or Ustekinumab or Placebo
Phase 2b/3
Study site University of North Carolina
Study location Chapel Hill
Principal investigator Animesh Jain ibdtrials@med.unc.edu
Study coordinator Emily English emily_english@med.unc.edu
Phone contact 919-843-8105
Clinicaltrials.gov link https://clinicaltrials.gov/ct2/show/NCT04033445

ADDRESS


1112 Harding Place
Suite 100
Charlotte NC 28204

Fax: 704.376.3173

LINKS


Home
Education
Events
Research
JOIN NOW

CONTACT


704.376.3688
sbuchanan@meckmed.org

Copyright: North Carolina Society of Gastroenterology (NCSG)
JOIN or RENEW HERE